eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Leena Bhola - Comment

Leena Bhola - Comment

Document ID: FDA-2011-N-0443-0009
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: September 06 2011, at 12:00 AM Eastern Daylight Time
Date Posted: September 28 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: June 22 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: September 23 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f12833
View Document:  View as format xml

View Comment

I think amongst clinical outcomes: Health related quality of life assessment should form an important health outcome measure. If smokers quitting cigarettes can have an improvement in QoL, MRTPs should also show an improvement in QoL.

Related Comments

    View All
Total: 56
American Cancer Society (ACS), Cancer Action Network (CAN), American Heart Association (AHA), American Lung Association (ALA), Campaign for Tobacco-Free Kids (TFK), American Public Health Association (APHA) - Comment
Public Submission    Posted: 09/23/2011     ID: FDA-2011-N-0443-0003

Sep 23,2011 11:59 PM ET
Jim Tozzi (Center for Regulatory Effectiveness) - Testimony
Public Submission    Posted: 09/28/2011     ID: FDA-2011-N-0443-0006

Sep 23,2011 11:59 PM ET
Gilbert Ross M.D. - Testimony
Public Submission    Posted: 09/28/2011     ID: FDA-2011-N-0443-0007

Sep 23,2011 11:59 PM ET
Patrick Johnson - Comment
Public Submission    Posted: 09/28/2011     ID: FDA-2011-N-0443-0008

Sep 23,2011 11:59 PM ET
Leena Bhola - Comment
Public Submission    Posted: 09/28/2011     ID: FDA-2011-N-0443-0009

Sep 23,2011 11:59 PM ET